Healthcare -
Biotechnology - NASDAQ - US
$ 2.89
-1.03 %
$ 1.75 B
Market Cap
-9.03
P/E
GERN - OTHER CURRENT LIABILITIES
Other Current Liabilities GERN - Geron Corporation
54.1 M
LAST VALUE
20.83%
2 YEAR CAGR
52.44%
5 YEAR CAGR
24.20%
10 YEAR CAGR